Literature DB >> 15821900

[Infections after organ transplantation].

W V Kern1, D Wagner, H H Hirsch.   

Abstract

Early postoperative infections after transplantation vary according to the transplanted organ. During the subsequent course opportunistic infections such as cytomegalovirus reactivation, Pneumocystis jiroveci pneumonia, invasive pneumococcal infection and mould infections predominate. Reactivated tuberculous infection appears to become more prevalent. Some of the opportunistic infections are preventable by chemoprophylaxis; others can be managed very effectively by monitoring and early preemptive therapy. Physicians caring for patients after organ transplantation need to early consider in the differential diagnosis rare pathogens which are often overlooked with standard diagnostic procedures.

Entities:  

Mesh:

Year:  2005        PMID: 15821900     DOI: 10.1007/s00108-005-1400-2

Source DB:  PubMed          Journal:  Internist (Berl)        ISSN: 0020-9554            Impact factor:   0.743


  46 in total

1.  Herpes zoster infection following solid organ transplantation: incidence, risk factors and outcomes in the current immunosuppressive era.

Authors:  Sita Gourishankar; Jill C McDermid; Gian S Jhangri; Jutta K Preiksaitis
Journal:  Am J Transplant       Date:  2004-01       Impact factor: 8.086

Review 2.  Pneumocystis pneumonia.

Authors:  Charles F Thomas; Andrew H Limper
Journal:  N Engl J Med       Date:  2004-06-10       Impact factor: 91.245

Review 3.  [Hepatitis 2004: an update].

Authors:  Hubert E Blum
Journal:  Ther Umsch       Date:  2004-08

4.  Valacyclovir for the prevention of cytomegalovirus disease after renal transplantation. International Valacyclovir Cytomegalovirus Prophylaxis Transplantation Study Group.

Authors:  D Lowance; H H Neumayer; C M Legendre; J P Squifflet; J Kovarik; P J Brennan; D Norman; R Mendez; M R Keating; G L Coggon; A Crisp; I C Lee
Journal:  N Engl J Med       Date:  1999-05-13       Impact factor: 91.245

Review 5.  Current outcomes following heart transplantation.

Authors:  James K Kirklin; Salpy V Pambukian; David C McGiffin; Raymond L Benza
Journal:  Semin Thorac Cardiovasc Surg       Date:  2004

6.  Risk factors for post-transplant tuberculosis.

Authors:  G T John; V Shankar; A M Abraham; U Mukundan; P P Thomas; C K Jacob
Journal:  Kidney Int       Date:  2001-09       Impact factor: 10.612

7.  Randomized multicenter trial of foscarnet versus ganciclovir for preemptive therapy of cytomegalovirus infection after allogeneic stem cell transplantation.

Authors:  Pierre Reusser; Hermann Einsele; John Lee; Liisa Volin; Montserrat Rovira; Dan Engelhard; Jürgen Finke; Catherine Cordonnier; Hartmut Link; Per Ljungman
Journal:  Blood       Date:  2002-02-15       Impact factor: 22.113

Review 8.  Polyomavirus nephropathy: morphology, pathophysiology, and clinical management.

Authors:  Volker Nickeleit; Harsharan K Singh; Michael J Mihatsch
Journal:  Curr Opin Nephrol Hypertens       Date:  2003-11       Impact factor: 2.894

Review 9.  Vaccinations for adult solid-organ transplant recipients: current recommendations and protocols.

Authors:  Andrea Duchini; John A Goss; Saul Karpen; Paul J Pockros
Journal:  Clin Microbiol Rev       Date:  2003-07       Impact factor: 26.132

10.  Safety and efficacy of isoniazid chemoprophylaxis administered during liver transplant candidacy for the prevention of posttransplant tuberculosis.

Authors:  Nina Singh; Marilyn M Wagener; Timothy Gayowski
Journal:  Transplantation       Date:  2002-09-27       Impact factor: 4.939

View more
  1 in total

1.  [Skin infections after transplantation].

Authors:  I H Wolf
Journal:  Hautarzt       Date:  2010-03       Impact factor: 0.751

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.